EISAI Overview
Upcoming Projects (EISAI)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (EISAI)
-
A Second View: Discussing the Alzheimer's landscape with focus on Biogen's Lecanemab in light of the recent FDA approval
Tickers: EISAI, BIIB
Executed On: Jun 21, 2023 at 05:15 PM EDT -
Discussing the Alzheimer's landscape with focus on Biogen's Lecanemab in light of the recent FDA approval
Tickers: EISAI, BIIB
Executed On: Jun 20, 2023 at 05:00 PM EDT -
A Third View: Discussing the Alzheimer's landscape with focus on Biogen's Lecanemab in light of the recent phase 3 topline data
Tickers: BIIB, Eisai
Executed On: Oct 06, 2022 at 12:30 PM EDT -
A Second View: Discussing the Alzheimer's landscape with focus on Biogen's Lecanemab in light of the recent phase 3 topline data
Tickers: BIIB, Eisai
Executed On: Oct 03, 2022 at 06:30 PM EDT -
Discussing the Alzheimer's landscape with focus on Biogen's Lecanemab in light of the recent phase 3 topline data
Tickers: BIIB, Eisai
Executed On: Oct 03, 2022 at 04:45 PM EDT
Upcoming & Overdue Catalysts (EISAI)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (EISAI)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
